Improving FDA’s COVID-19 vaccine authorization and approval process
HANOVER, N.H. – Aug. 31, 2020 – On March 28, the Food and Drug Administration (FDA) exercised its Emergency Use Authorization (EUA) authority to allow the use of hydroxychloroquine for the treatment of COVID-19. On June 15, after a number of studies failed to find positive effects, the agency revoked this authorization. This chain of…
Details